Acrivon Therapeutics (ACRV) Return on Assets [ROA] (2022 - 2026)
Acrivon Therapeutics (ACRV) posted Return on Assets [ROA] of -75.75% for Q2 2026, down 19.38 percentage points from -56.37% a year earlier and down 6.41 percentage points from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Return on Assets [ROA] (2022 - 2026) Analysis & Trends
For FY2025, Acrivon Therapeutics' Return on Assets [ROA] came in at -51.56%, up 1.72 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a three-year change of -29.90 percentage points (FY2022 to FY2025).
- In prior years, Acrivon Therapeutics' Return on Assets [ROA] was -53.28% in FY2024 (-11.27 pp), -42.01% in FY2023 (-20.35 pp) and -21.66% in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q4 2022.
- On a year-over-year basis, Return on Assets [ROA] has declined in each of the last five quarters, with an average year-over-year change of -10.65 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2025, with a gain of 4.41 percentage points; the weakest was Q1 2024, with a drop of 32.51 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -69.34% (Q1 2026), -61.17% (Q4 2025) and -58.54% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Acrivon Therapeutics | 67.27 Mn | -368.26 Mn | - | -71.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -71.88% |
| Mar 31, 2026 | -65.29% |
| Dec 31, 2025 | -56.90% |
| Sep 30, 2025 | -54.25% |
| Jun 30, 2025 | -51.25% |
| Mar 31, 2025 | -44.72% |
| Dec 31, 2024 | -38.92% |
| Sep 30, 2024 | -34.09% |
| Jun 30, 2024 | -39.07% |
| Mar 31, 2024 | -49.61% |
| Dec 31, 2023 | -41.73% |
| Sep 30, 2023 | -32.31% |
| Jun 30, 2023 | -27.33% |
| Mar 31, 2023 | -20.83% |
| Dec 31, 2022 | -23.18% |
API Access
Acrivon Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();